Registration Opens for SMi's 21st Annual Pain Therapeutics Virtual Conference
SMi Reports: The leading Pain Therapeutics Conference will take place for its 21st consecutive year as a virtual conference to explore cutting edge drug discovery science and key clinical-stage pain therapies in the pipeline
By: SMi Group
The conference will focus on looking into research within pain therapeutics. In particular, the long-term (HEAL) initiative will be discussed and its role in advancing research to reduce the risks of opioid use and misuse and improve pain management, thereby reducing reliance on opioids and the national opioid public health crisis.
The conference also address cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies, with a focus on highlighting the importance of biomarker discovery and its contribution to early stage studies on pain. This will be topped off with a panel debate on rethinking pain clinical trials during the COVID-19 pandemic. And further look into treating painful osteoarthritis of the knee with a novel anti NGF, anti-TNFa bispecific fusion protein as well as therapeutic novelties signifying a paradigm shift in migraine prevention.
You can download the brochure at www.pain-therapeutics.co.uk.
Interested parties should register at http://www.pain-
The full agenda and speaker line-up can be viewed online at http://www.pain-
Proudly sponsored by: Transpharmation
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or email@example.com
SMi's 21st Annual Pain Therapeutics Virtual Conference
Conference: 10th – 11th May 2021
Virtual Conference: Online Access Only